{
    "root": "312ef3fd-bb47-dd83-e063-6294a90a262a",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Chorionic Gonadotropin",
    "value": "20250325",
    "ingredients": [],
    "indications": "HCG HAS NOT BEEN DEMONSTRATED TO BE EFFECTIVE ADJUNCTIVE THERAPY IN THE TREATMENT OF OBESITY.  THERE IS NO SUBSTANTIAL EVIDENCE THAT IT INCREASES WEIGHT LOSS BEYOND THAT RESULTING FROM CALORIC RESTRICTION, THAT IT CAUSES A MORE ATTRACTIVE OR ‘‘NORMAL’’ DISTRIBUTION OF FAT, OR THAT IT DECREASES THE HUNGER AND DISCOMFORT ASSOCIATED WITH CALORIE-RESTRICTED DIETS.\n                  \n                     Prepubertal cryptorchidism not due to anatomical obstruction.  In general, HCG is thought to induce testicular descent in situations when descent would have occurred at puberty.  HCG thus may help predict whether or not orchiopexy will be needed in the future.  Although, in some cases, descent following HCG administration is permanent, in most cases, the response is temporary.  Therapy is usually instituted between the ages four and nine.\n                     Selected cases of hypogonadotropic hypogonadism (hypogonadism secondary to a pituitary deficiency) in males.\n                     Induction of ovulation and pregnancy in the anovulatory, infertile woman in whom the cause of anovulation is secondary and not due to primary ovarian failure, and who has been appropriately pretreated with human menotropins.",
    "contraindications": "The dosage regimen employed in any particular case will depend upon the indication for use, the age and weight of the patient and the physician’s preference.  The following regimens have been advocated by various authorities.",
    "warningsAndPrecautions": null,
    "adverseReactions": "Precocious puberty, prostatic carcinoma or other androgen-dependent neoplasm, prior allergic reaction to HCG."
}